Indian drugmaker Sun Pharma says Halol plant has gained U.S. clearance


MUMBAI (Reuters) – Supply restrictions imposed on India’s largest drugmaker Sun Pharmaceutical Industries by U.S. regulators have been lifted, the company said on Tuesday, removing a major drag on its share price.

Sun will now be able to resume shipments of drugs made at its Halol factory in western India, which contributed as much as 15 percent to its U.S. revenue in 2015. The restrictions on some drugs made at the site had been imposed after an inspection revealed quality control failures.

The world’s fifth-largest generic drugs maker has been working on fixing problems identified by…



Read More Here

Be the first to comment on "Indian drugmaker Sun Pharma says Halol plant has gained U.S. clearance"

Leave a comment

Your email address will not be published.


*